Literature DB >> 889726

The effect of intravenous salbutamol upon plasma and urinary potassium during premature labour.

S K Smith, D Thompson.   

Abstract

Plasma potassium and urinary potassium excretion were measured in eight patients in premature labour treated with salbutamol, and in ten patients at full term in spontaneous labour. There was a significant fall in plasma potassium concentration following salbutamol infusion, but no change during labour in the control groups. Urinary potassium excretion was similar in both groups.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 889726     DOI： 10.1111/j.1471-0528.1977.tb12596.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN： 0306-5456


  7 in total

1.  Salbutamol: beware of the paradox!

Authors:  R Saxena; G Marais
Journal:  BMJ Case Rep       Date:  2010-09-29

2.  Management of premature labour in diabetic pregnancy.

Authors:  A H Barnett; S M Stubbs; A M Mander
Journal:  Diabetologia       Date:  1980-05       Impact factor: 10.122

3.  Pharmacokinetics of intravenous salbutamol in renal insufficiency and its biological effects.

Authors:  E Rey; L Luquel; M O Richard; B Mory; G Offenstadt; G Olive
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  The mechanism of salbutamol-induced hypokalaemia.

Authors:  K F Whyte; G J Addis; R Whitesmith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

5.  The effect of intravenously administered salbutamol on serum potassium in asthmatic and nonasthmatic atopic subjects.

Authors:  L Marazzini; A Pelucchi; M Bozzoni; B Mastropasqua; E Longhini
Journal:  J Clin Immunol       Date:  1985-05       Impact factor: 8.317

6.  Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure.

Authors:  R Canepa-Anson; J R Dawson; P Kuan; P A Poole-Wilson; G C Sutton; B Cockrill; S R Reuben
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

7.  Metabolic and cardiovascular side effects of the beta 2-adrenoceptor agonists salbutamol and rimiterol.

Authors:  P J Phillips; A E Vedig; P L Jones; M G Chapman; M Collins; J B Edwards; T C Smeaton; B M Duncan
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.